Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Breast Cancer Research and Treatment|March 2, 2010
Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cellsDemissew S Mern, Karin Hoppe-Seyler, Felix Hoppe-Seyler, et al.
European Journal of Endocrinology|March 3, 2012
Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I studyHartmut Dietrich, Ke Hu, Matthieu Ruffin, et al.
Leukemia & Lymphoma|November 9, 2010
Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myelomaJens Hasskarl, Gabriele Ihorst, David De Pasquale, et al.
Cancer Research|January 25, 2003
Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instabilitySiribang-on Piboonniyom, Stefan Duensing, Nathan W Swilling, et al.
BMC Cell Biology|January 15, 2010
Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cellsCarolin Manthey, Demissew S Mern, Anja Gutmann, et al.
Journal of Herbal Pharmacotherapy|April 15, 2005
Boswellia: an evidence-based systematic review by the Natural Standard Research CollaborationEthan Basch, Heather Boon, Theresa Davies-Heerema, et al.
Case Reports in Oncology|August 27, 2010
Severe Organizing Pneumonia after Two Cycles of Docetaxel as Fourth-Line Chemotherapy for Advanced Non-Small Cell Carcinoma of the LungJens Hasskarl, Percy Schroettner, Andrea von den Berg, et al.
World Journal of Gastroenterology|January 11, 2014
Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancerJan Harder, Michael J Müller, Matthias Fuchs, et al.
Histochemistry and Cell Biology|December 3, 2013
ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypesAnnette M May, Anna-Verena Frey, Lioudmila Bogatyreva, et al.
Experimental Hematology & Oncology|March 26, 2022
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucelGuillaume Cartron, Christopher P Fox, Fei Fei Liu, et al.
Pageof 3